About
Join us for an insightful presentation by Dr. Stacy D’Andre, a board‐certified oncologist at Mayo Clinic with a dedicated focus on integrative oncology, including the safe and evidence‐informed use of medical cannabis and medicinal mushrooms.
In this session, Dr. D’Andre will:
- Provide an update on her recent research efforts in medical cannabis for oncology‐related symptom management—such as her pilot randomized placebo‐controlled trial of topical cannabidiol for chemotherapy‐induced neuropathy.
- Explore emerging work and considerations around psychedelic therapies in the context of cancer care and supportive medicine—highlighting the overlap in patient populations, clinical questions, and integrative care frameworks.
- Discuss the practical implications for clinicians: how to address patient inquiries about cannabis or psychedelic‐adjunctive therapies, integrate conversations into care plans, evaluate the growing body of evidence, and incorporate best practices in an evolving regulatory and clinical landscape.